Atig, Marilou .
HRN: 24-77-66 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/29/2024
CEFUROXIME 500MG (TAB)
03/29/2024
04/05/2024
PO
500 Mg Tab
BID
NSVD; Thinly Meconium-stained Amniotic Fluid
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft TissueUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes